Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4Y7T

Structural analysis of MurU

Summary for 4Y7T
Entry DOI10.2210/pdb4y7t/pdb
DescriptorNucleotidyl transferase, GLYCEROL, SULFATE ION, ... (4 entities in total)
Functional Keywordsnucleotidyltransferase family protein, uridyltransferase, rossman fold, transferase
Biological sourcePseudomonas putida
Total number of polymer chains1
Total formula weight25481.81
Authors
Renner-Schneck, M.G.,Stehle, T. (deposition date: 2015-02-16, release date: 2015-03-18, Last modification date: 2024-05-08)
Primary citationRenner-Schneck, M.,Hinderberger, I.,Gisin, J.,Exner, T.,Mayer, C.,Stehle, T.
Crystal Structure of the N-Acetylmuramic Acid alpha-1-Phosphate (MurNAc-alpha 1-P) Uridylyltransferase MurU, a Minimal Sugar Nucleotidyltransferase and Potential Drug Target Enzyme in Gram-negative Pathogens.
J.Biol.Chem., 290:10804-10813, 2015
Cited by
PubMed Abstract: The N-acetylmuramic acid α-1-phosphate (MurNAc-α1-P) uridylyltransferase MurU catalyzes the synthesis of uridine diphosphate (UDP)-MurNAc, a crucial precursor of the bacterial peptidoglycan cell wall. MurU is part of a recently identified cell wall recycling pathway in Gram-negative bacteria that bypasses the general de novo biosynthesis of UDP-MurNAc and contributes to high intrinsic resistance to the antibiotic fosfomycin, which targets UDP-MurNAc de novo biosynthesis. To provide insights into substrate binding and specificity, we solved crystal structures of MurU of Pseudomonas putida in native and ligand-bound states at high resolution. With the help of these structures, critical enzyme-substrate interactions were identified that enable tight binding of MurNAc-α1-P to the active site of MurU. The MurU structures define a "minimal domain" required for general nucleotidyltransferase activity. They furthermore provide a structural basis for the chemical design of inhibitors of MurU that could serve as novel drugs in combination therapy against multidrug-resistant Gram-negative pathogens.
PubMed: 25767118
DOI: 10.1074/jbc.M114.620989
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.8 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon